| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 15 | 2013 | 72 | 1.970 |
Why?
|
| Brachial Plexus Neuropathies | 3 | 2016 | 39 | 0.860 |
Why?
|
| Radius Fractures | 8 | 2015 | 68 | 0.720 |
Why?
|
| Range of Motion, Articular | 9 | 2015 | 196 | 0.630 |
Why?
|
| Muscle, Skeletal | 9 | 2011 | 520 | 0.620 |
Why?
|
| Muscle Spasticity | 6 | 2013 | 26 | 0.610 |
Why?
|
| Fingers | 7 | 2015 | 75 | 0.590 |
Why?
|
| Nerve Transfer | 2 | 2016 | 19 | 0.560 |
Why?
|
| Brachial Plexus | 2 | 2016 | 28 | 0.550 |
Why?
|
| Orthopedic Procedures | 5 | 2011 | 91 | 0.480 |
Why?
|
| Radial Nerve | 1 | 2016 | 18 | 0.470 |
Why?
|
| Neuromuscular Agents | 6 | 2012 | 36 | 0.460 |
Why?
|
| Fracture Fixation | 4 | 2006 | 42 | 0.460 |
Why?
|
| Male | 43 | 2016 | 19441 | 0.400 |
Why?
|
| Complex Regional Pain Syndromes | 5 | 2016 | 24 | 0.400 |
Why?
|
| Fracture Fixation, Internal | 5 | 2010 | 125 | 0.390 |
Why?
|
| Humans | 60 | 2016 | 32282 | 0.390 |
Why?
|
| Treatment Outcome | 16 | 2016 | 3416 | 0.380 |
Why?
|
| Wrist Joint | 4 | 2015 | 57 | 0.370 |
Why?
|
| Botulinum Toxins | 3 | 2008 | 30 | 0.370 |
Why?
|
| Child | 15 | 2013 | 2435 | 0.360 |
Why?
|
| Muscle Relaxants, Central | 2 | 2008 | 10 | 0.340 |
Why?
|
| Upper Extremity | 5 | 2015 | 68 | 0.330 |
Why?
|
| Baclofen | 2 | 2008 | 26 | 0.330 |
Why?
|
| Phenol | 2 | 2008 | 10 | 0.330 |
Why?
|
| Joint Deformities, Acquired | 1 | 2010 | 13 | 0.330 |
Why?
|
| X-Ray Microtomography | 1 | 2010 | 45 | 0.330 |
Why?
|
| Tendon Transfer | 1 | 2010 | 18 | 0.320 |
Why?
|
| Arm | 1 | 2010 | 42 | 0.320 |
Why?
|
| Birth Injuries | 1 | 2010 | 29 | 0.320 |
Why?
|
| Ischemia | 4 | 2015 | 115 | 0.320 |
Why?
|
| Osteotomy | 1 | 2010 | 55 | 0.310 |
Why?
|
| Female | 32 | 2016 | 19945 | 0.310 |
Why?
|
| Adolescent | 15 | 2016 | 3519 | 0.310 |
Why?
|
| Neurologic Examination | 2 | 2008 | 30 | 0.300 |
Why?
|
| GAP-43 Protein | 2 | 2007 | 8 | 0.290 |
Why?
|
| Receptors, Nicotinic | 3 | 2007 | 61 | 0.290 |
Why?
|
| Psychomotor Disorders | 1 | 2008 | 5 | 0.290 |
Why?
|
| Seasons | 1 | 2009 | 73 | 0.280 |
Why?
|
| Hemiplegia | 1 | 2008 | 10 | 0.280 |
Why?
|
| Quadriplegia | 1 | 2008 | 11 | 0.280 |
Why?
|
| Scoliosis | 1 | 2008 | 20 | 0.280 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2005 | 42 | 0.280 |
Why?
|
| Shoulder Joint | 1 | 2010 | 139 | 0.280 |
Why?
|
| Arthroscopy | 4 | 2005 | 242 | 0.260 |
Why?
|
| Knee Joint | 3 | 2015 | 128 | 0.250 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2010 | 56 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2012 | 897 | 0.250 |
Why?
|
| Patella | 2 | 2005 | 19 | 0.240 |
Why?
|
| Adult | 21 | 2016 | 9259 | 0.240 |
Why?
|
| Ligaments, Articular | 3 | 2005 | 41 | 0.240 |
Why?
|
| Postoperative Complications | 5 | 2016 | 823 | 0.230 |
Why?
|
| Injections, Intramuscular | 9 | 2013 | 53 | 0.230 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 2240 | 0.220 |
Why?
|
| Rats | 9 | 2012 | 1895 | 0.220 |
Why?
|
| Leg Injuries | 1 | 2004 | 12 | 0.220 |
Why?
|
| Foot Injuries | 1 | 2004 | 13 | 0.210 |
Why?
|
| Scaphoid Bone | 1 | 2004 | 8 | 0.210 |
Why?
|
| Recovery of Function | 4 | 2016 | 239 | 0.210 |
Why?
|
| Retrospective Studies | 10 | 2016 | 3626 | 0.210 |
Why?
|
| Lunate Bone | 1 | 2004 | 11 | 0.210 |
Why?
|
| RNA, Messenger | 2 | 2007 | 499 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 124 | 0.210 |
Why?
|
| Fracture Fixation, Intramedullary | 2 | 2015 | 40 | 0.200 |
Why?
|
| Prospective Studies | 8 | 2016 | 2316 | 0.200 |
Why?
|
| Parasympatholytics | 1 | 2003 | 5 | 0.200 |
Why?
|
| Joint Instability | 3 | 2015 | 89 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2005 | 243 | 0.200 |
Why?
|
| Radiography | 5 | 2014 | 363 | 0.200 |
Why?
|
| Cartilage, Articular | 2 | 2005 | 72 | 0.200 |
Why?
|
| Ligaments | 1 | 2003 | 12 | 0.200 |
Why?
|
| Neuromuscular Junction | 4 | 2011 | 70 | 0.200 |
Why?
|
| Multiple Trauma | 1 | 2003 | 41 | 0.190 |
Why?
|
| Wrist Injuries | 1 | 2003 | 41 | 0.190 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2013 | 65 | 0.180 |
Why?
|
| Raynaud Disease | 3 | 2011 | 13 | 0.180 |
Why?
|
| Brachial Artery | 1 | 2002 | 72 | 0.170 |
Why?
|
| Humeral Fractures | 1 | 2002 | 36 | 0.170 |
Why?
|
| Pain, Postoperative | 3 | 2016 | 199 | 0.170 |
Why?
|
| Muscle Tonus | 2 | 2011 | 7 | 0.170 |
Why?
|
| Animals | 14 | 2012 | 8199 | 0.170 |
Why?
|
| Bone Plates | 2 | 2015 | 71 | 0.160 |
Why?
|
| Bone Nails | 2 | 2015 | 39 | 0.160 |
Why?
|
| Child, Preschool | 6 | 2013 | 1233 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2016 | 95 | 0.150 |
Why?
|
| Muscle Strength | 3 | 2011 | 135 | 0.150 |
Why?
|
| Athletic Injuries | 2 | 2013 | 83 | 0.140 |
Why?
|
| Muscle Contraction | 4 | 2013 | 175 | 0.130 |
Why?
|
| Hand | 4 | 2012 | 79 | 0.130 |
Why?
|
| Sympathectomy | 3 | 2008 | 23 | 0.130 |
Why?
|
| Fractures, Comminuted | 3 | 2007 | 11 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 1083 | 0.130 |
Why?
|
| Analgesics, Opioid | 2 | 2016 | 252 | 0.120 |
Why?
|
| External Fixators | 2 | 2008 | 18 | 0.120 |
Why?
|
| Injections, Spinal | 2 | 2008 | 119 | 0.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2016 | 17 | 0.120 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2016 | 15 | 0.120 |
Why?
|
| Middle Aged | 13 | 2015 | 11851 | 0.120 |
Why?
|
| Bupivacaine | 1 | 2016 | 51 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 85 | 0.110 |
Why?
|
| Quality of Life | 5 | 2013 | 964 | 0.110 |
Why?
|
| Median Nerve | 2 | 2006 | 50 | 0.110 |
Why?
|
| Young Adult | 3 | 2016 | 2649 | 0.100 |
Why?
|
| Rotator Cuff | 2 | 2013 | 75 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 242 | 0.100 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 37 | 0.100 |
Why?
|
| Transplantation, Homologous | 4 | 2010 | 158 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 63 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2016 | 65 | 0.100 |
Why?
|
| Muscle Denervation | 2 | 2011 | 29 | 0.100 |
Why?
|
| Hand Injuries | 2 | 2010 | 24 | 0.100 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2005 | 191 | 0.100 |
Why?
|
| Incidence | 3 | 2016 | 1241 | 0.100 |
Why?
|
| Algorithms | 2 | 2010 | 536 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2013 | 30 | 0.100 |
Why?
|
| Hyperhidrosis | 1 | 2012 | 6 | 0.100 |
Why?
|
| Femoral Fractures | 1 | 2013 | 43 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2015 | 276 | 0.090 |
Why?
|
| Disabled Children | 2 | 2003 | 21 | 0.090 |
Why?
|
| Linear Models | 2 | 2015 | 425 | 0.090 |
Why?
|
| North Carolina | 4 | 2014 | 1300 | 0.090 |
Why?
|
| Time Factors | 5 | 2014 | 2205 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2010 | 136 | 0.090 |
Why?
|
| Clubfoot | 2 | 2008 | 5 | 0.090 |
Why?
|
| Models, Biological | 2 | 2011 | 408 | 0.090 |
Why?
|
| Medicaid | 2 | 2002 | 101 | 0.090 |
Why?
|
| Ulnar Nerve Compression Syndromes | 1 | 2010 | 3 | 0.080 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 231 | 0.080 |
Why?
|
| Ganglion Cysts | 1 | 2010 | 8 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2009 | 666 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 534 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 124 | 0.080 |
Why?
|
| Menisci, Tibial | 1 | 2010 | 20 | 0.080 |
Why?
|
| Robotics | 1 | 2011 | 133 | 0.080 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 15 | 0.080 |
Why?
|
| Recurrence | 3 | 2012 | 285 | 0.080 |
Why?
|
| Bacterial Capsules | 1 | 2009 | 4 | 0.070 |
Why?
|
| Microscopy, Atomic Force | 1 | 2009 | 8 | 0.070 |
Why?
|
| Bacterial Adhesion | 1 | 2009 | 6 | 0.070 |
Why?
|
| Forearm | 2 | 2007 | 44 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 717 | 0.070 |
Why?
|
| Birth Rate | 1 | 2009 | 1 | 0.070 |
Why?
|
| Foot Ulcer | 1 | 2008 | 5 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 55 | 0.070 |
Why?
|
| Atrophy | 2 | 2006 | 46 | 0.070 |
Why?
|
| Occupational Therapy | 1 | 2008 | 5 | 0.070 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2008 | 9 | 0.070 |
Why?
|
| Age Factors | 2 | 2010 | 1179 | 0.070 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2008 | 6 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 62 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2009 | 174 | 0.070 |
Why?
|
| Observer Variation | 1 | 2008 | 96 | 0.070 |
Why?
|
| Musculoskeletal Diseases | 1 | 2008 | 33 | 0.070 |
Why?
|
| Cold Temperature | 2 | 2011 | 56 | 0.070 |
Why?
|
| Hemophilia A | 1 | 2008 | 22 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 19 | 0.070 |
Why?
|
| Transplantation, Autologous | 2 | 2005 | 100 | 0.070 |
Why?
|
| Amputation | 3 | 2015 | 44 | 0.070 |
Why?
|
| Bone Transplantation | 2 | 2005 | 51 | 0.070 |
Why?
|
| Debridement | 2 | 2010 | 45 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2008 | 34 | 0.070 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2007 | 9 | 0.070 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Paralysis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Thrombocythemia, Essential | 1 | 2007 | 3 | 0.070 |
Why?
|
| Cadaver | 2 | 2005 | 151 | 0.070 |
Why?
|
| Orthopedics | 1 | 2008 | 93 | 0.070 |
Why?
|
| Electromyography | 2 | 2011 | 67 | 0.070 |
Why?
|
| Achilles Tendon | 1 | 2007 | 26 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2009 | 368 | 0.070 |
Why?
|
| Movement Disorders | 2 | 2004 | 25 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 431 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 413 | 0.060 |
Why?
|
| Osteogenesis, Distraction | 1 | 2006 | 17 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 591 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2008 | 854 | 0.060 |
Why?
|
| Paresis | 1 | 2006 | 18 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 757 | 0.060 |
Why?
|
| Finger Injuries | 1 | 2006 | 8 | 0.060 |
Why?
|
| Finger Phalanges | 1 | 2006 | 7 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 3900 | 0.060 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2005 | 13 | 0.060 |
Why?
|
| Transplantation Immunology | 1 | 2005 | 30 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 478 | 0.060 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 8 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2005 | 40 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2005 | 50 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2005 | 40 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2005 | 66 | 0.050 |
Why?
|
| Household Articles | 1 | 2004 | 1 | 0.050 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 23 | 0.050 |
Why?
|
| Vacuum | 1 | 2004 | 23 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2004 | 76 | 0.050 |
Why?
|
| Foot Deformities | 1 | 2004 | 2 | 0.050 |
Why?
|
| Aged | 6 | 2015 | 10263 | 0.050 |
Why?
|
| Ankle | 1 | 2004 | 28 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2010 | 695 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2006 | 142 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2004 | 36 | 0.050 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 2004 | 15 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2005 | 1840 | 0.050 |
Why?
|
| Gait | 1 | 2004 | 120 | 0.050 |
Why?
|
| Diazepam | 1 | 2003 | 5 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2004 | 95 | 0.050 |
Why?
|
| Walking | 1 | 2004 | 200 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2004 | 84 | 0.050 |
Why?
|
| Length of Stay | 1 | 2004 | 321 | 0.050 |
Why?
|
| Equinus Deformity | 1 | 2003 | 4 | 0.050 |
Why?
|
| Ulnar Nerve | 1 | 2003 | 24 | 0.050 |
Why?
|
| Self Concept | 1 | 2003 | 45 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2002 | 50 | 0.050 |
Why?
|
| Scleroderma, Localized | 1 | 2002 | 6 | 0.050 |
Why?
|
| Pulse | 1 | 2002 | 9 | 0.040 |
Why?
|
| Bone Wires | 1 | 2002 | 11 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 84 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2002 | 44 | 0.040 |
Why?
|
| Reference Values | 2 | 2013 | 238 | 0.040 |
Why?
|
| Equipment Design | 2 | 2013 | 178 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2002 | 83 | 0.040 |
Why?
|
| Ethanol | 1 | 2003 | 195 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 55 | 0.040 |
Why?
|
| Caregivers | 1 | 2002 | 114 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 85 | 0.040 |
Why?
|
| Mice | 3 | 2011 | 2571 | 0.040 |
Why?
|
| Disability Evaluation | 2 | 2015 | 242 | 0.040 |
Why?
|
| Microcirculation | 2 | 2012 | 66 | 0.040 |
Why?
|
| Random Allocation | 2 | 2011 | 247 | 0.030 |
Why?
|
| Injections | 2 | 2011 | 72 | 0.030 |
Why?
|
| Laser-Doppler Flowmetry | 2 | 2011 | 34 | 0.030 |
Why?
|
| Medical History Taking | 2 | 2010 | 39 | 0.030 |
Why?
|
| Physical Examination | 2 | 2010 | 86 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 556 | 0.030 |
Why?
|
| Splints | 2 | 2010 | 13 | 0.030 |
Why?
|
| Extremities | 1 | 2016 | 54 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 942 | 0.030 |
Why?
|
| Anesthesia, Local | 1 | 2016 | 15 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2016 | 18 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 19 | 0.030 |
Why?
|
| Liposomes | 1 | 2016 | 34 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 77 | 0.030 |
Why?
|
| Infant | 3 | 2004 | 1010 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 315 | 0.030 |
Why?
|
| Nerve Block | 1 | 2016 | 57 | 0.030 |
Why?
|
| Fractures, Closed | 1 | 2015 | 9 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 200 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 44 | 0.030 |
Why?
|
| Casts, Surgical | 2 | 2006 | 23 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 150 | 0.030 |
Why?
|
| Computer Systems | 1 | 2013 | 15 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2013 | 26 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 44 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 324 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 253 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2013 | 21 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2012 | 8 | 0.020 |
Why?
|
| Retreatment | 1 | 2012 | 42 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 130 | 0.020 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 24 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 276 | 0.020 |
Why?
|
| Yohimbine | 1 | 2012 | 7 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2012 | 14 | 0.020 |
Why?
|
| Sports | 1 | 2013 | 43 | 0.020 |
Why?
|
| Prazosin | 1 | 2012 | 11 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 94 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2006 | 393 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2011 | 16 | 0.020 |
Why?
|
| Autonomic Nerve Block | 1 | 2011 | 11 | 0.020 |
Why?
|
| Sweating | 1 | 2011 | 16 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 565 | 0.020 |
Why?
|
| Electric Stimulation Therapy | 1 | 2011 | 19 | 0.020 |
Why?
|
| Vasodilation | 1 | 2012 | 92 | 0.020 |
Why?
|
| Ketamine | 1 | 2011 | 20 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 883 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 34 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 59 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2011 | 29 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 505 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2011 | 60 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 74 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2011 | 82 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 96 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 853 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 128 | 0.020 |
Why?
|
| Tendons | 1 | 2011 | 50 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 155 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1534 | 0.020 |
Why?
|
| Phonophoresis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 111 | 0.020 |
Why?
|
| Iontophoresis | 1 | 2010 | 7 | 0.020 |
Why?
|
| Reaction Time | 1 | 2011 | 123 | 0.020 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 11 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 116 | 0.020 |
Why?
|
| Bandages | 1 | 2010 | 34 | 0.020 |
Why?
|
| Porosity | 1 | 2010 | 39 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 81 | 0.020 |
Why?
|
| Cicatrix | 1 | 2010 | 39 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2011 | 125 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 102 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 251 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 55 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2010 | 47 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 37 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 185 | 0.020 |
Why?
|
| Water | 1 | 2009 | 65 | 0.020 |
Why?
|
| Fasciitis, Plantar | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 341 | 0.020 |
Why?
|
| Contracture | 1 | 2008 | 16 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 11 | 0.020 |
Why?
|
| Tennis Elbow | 1 | 2008 | 15 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 16 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 955 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 223 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 35 | 0.020 |
Why?
|
| Arthroplasty, Replacement | 1 | 2008 | 14 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 54 | 0.020 |
Why?
|
| Foot | 1 | 2008 | 40 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 240 | 0.020 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2008 | 14 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2010 | 208 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 256 | 0.020 |
Why?
|
| Freezing | 1 | 2007 | 6 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2007 | 14 | 0.020 |
Why?
|
| Rupture | 1 | 2007 | 33 | 0.020 |
Why?
|
| Gangrene | 1 | 2007 | 5 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 471 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 38 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 89 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2007 | 60 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 246 | 0.020 |
Why?
|
| Arteries | 1 | 2007 | 75 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2006 | 5 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 11 | 0.020 |
Why?
|
| Myogenin | 1 | 2006 | 5 | 0.020 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2006 | 8 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2006 | 19 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 18 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 26 | 0.010 |
Why?
|
| Ankle Joint | 1 | 2006 | 43 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 3934 | 0.010 |
Why?
|
| Immobilization | 1 | 2006 | 9 | 0.010 |
Why?
|
| Collateral Ligaments | 1 | 2006 | 8 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 219 | 0.010 |
Why?
|
| Finger Joint | 1 | 2006 | 14 | 0.010 |
Why?
|
| Supination | 1 | 2005 | 6 | 0.010 |
Why?
|
| Pronation | 1 | 2005 | 6 | 0.010 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 50 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 188 | 0.010 |
Why?
|
| Radius | 1 | 2005 | 24 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2006 | 82 | 0.010 |
Why?
|
| Ulna | 1 | 2005 | 18 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 160 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 85 | 0.010 |
Why?
|
| Economics, Hospital | 1 | 2005 | 6 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 907 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 1224 | 0.010 |
Why?
|
| United States | 2 | 2005 | 4072 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 106 | 0.010 |
Why?
|
| Bone Screws | 1 | 2005 | 55 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2005 | 91 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 287 | 0.010 |
Why?
|
| Dystonic Disorders | 1 | 2004 | 6 | 0.010 |
Why?
|
| Baseball | 1 | 2005 | 48 | 0.010 |
Why?
|
| Hand Strength | 1 | 2004 | 98 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2004 | 50 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2003 | 25 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 773 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 51 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 273 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 651 | 0.010 |
Why?
|
| Hip | 1 | 2002 | 13 | 0.010 |
Why?
|
| Health Status | 1 | 2004 | 355 | 0.010 |
Why?
|
| Drug Utilization Review | 1 | 2002 | 12 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 14 | 0.010 |
Why?
|
| Psoas Muscles | 1 | 2002 | 16 | 0.010 |
Why?
|
| Social Support | 1 | 2003 | 180 | 0.010 |
Why?
|
| Drug Costs | 1 | 2002 | 46 | 0.010 |
Why?
|
| Health Surveys | 1 | 2002 | 175 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 191 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 757 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 1479 | 0.010 |
Why?
|